Clover Health Investments, Corp. $CLOV Stock Position Decreased by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. decreased its holdings in shares of Clover Health Investments, Corp. (NASDAQ:CLOV) by 5.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,611,133 shares of the company’s stock after selling 139,924 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 0.51% of Clover Health Investments worth $9,374,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Graham Capital Management L.P. bought a new position in shares of Clover Health Investments during the fourth quarter valued at approximately $889,000. Barclays PLC boosted its position in Clover Health Investments by 336.5% during the 4th quarter. Barclays PLC now owns 461,692 shares of the company’s stock valued at $1,454,000 after purchasing an additional 355,926 shares during the period. Millennium Management LLC grew its stake in Clover Health Investments by 5,071.2% during the 4th quarter. Millennium Management LLC now owns 1,245,701 shares of the company’s stock worth $3,924,000 after buying an additional 1,221,612 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Clover Health Investments by 90.7% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 830,457 shares of the company’s stock worth $2,616,000 after buying an additional 394,881 shares during the last quarter. Finally, Perigon Wealth Management LLC acquired a new stake in Clover Health Investments in the first quarter worth $36,000. 19.77% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Clover Health Investments

In other news, Director Anna U. Loengard bought 26,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 13th. The shares were purchased at an average price of $2.59 per share, with a total value of $68,635.00. Following the completion of the acquisition, the director directly owned 29,610 shares in the company, valued at approximately $76,689.90. This trade represents a 852.09% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Conrad Wai sold 118,600 shares of the company’s stock in a transaction that occurred on Tuesday, July 22nd. The stock was sold at an average price of $3.29, for a total value of $390,194.00. Following the completion of the sale, the chief executive officer owned 1,494,898 shares of the company’s stock, valued at $4,918,214.42. This trade represents a 7.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 24.07% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on CLOV shares. UBS Group reduced their price target on shares of Clover Health Investments from $4.50 to $3.00 and set a “neutral” rating for the company in a report on Wednesday, August 6th. Canaccord Genuity Group cut their price objective on shares of Clover Health Investments from $4.50 to $4.10 and set a “buy” rating on the stock in a research report on Thursday, August 7th. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, Clover Health Investments has a consensus rating of “Moderate Buy” and an average price target of $4.37.

Clover Health Investments Stock Down 3.3%

Shares of CLOV opened at $2.64 on Tuesday. The firm has a market capitalization of $1.35 billion, a PE ratio of -33.00 and a beta of 1.91. The firm has a 50-day moving average price of $2.80 and a 200 day moving average price of $3.32. Clover Health Investments, Corp. has a 52-week low of $2.12 and a 52-week high of $4.87.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.